Decoy Therapeutics is trading at $5.42 (6% down) following a Form S-1 filing for warrant resale and a going-concern warning.
- The July 13 filing registers the resale of warrant shares, triggering significant dilution concerns that have extended a sharp pullback over the past week.
- An accompanying going-concern warning has raised solvency issues, weighing heavily on investor sentiment for this thinly traded micro-cap biotech stock.